Candriam SCA’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-276,300
| Closed | -$2.04M | – | 659 |
|
|
2023
Q2 | $2.04M | Buy |
276,300
+20,000
| +8% | +$148K | 0.01% | 491 |
|
|
2023
Q1 | $1.93M | Buy |
256,300
+94,000
| +58% | +$708K | 0.01% | 584 |
|
|
2022
Q4 | $1.55M | Sell |
162,300
-9,000
| -5% | -$86.1K | 0.01% | 621 |
|
|
2022
Q3 | $2.01M | Buy |
171,300
+12,000
| +8% | +$141K | 0.01% | 583 |
|
|
2022
Q2 | $2.05M | Hold |
159,300
| – | – | 0.02% | 503 |
|
|
2022
Q1 | $1.75M | Buy |
159,300
+109,000
| +217% | +$1.2M | 0.01% | 571 |
|
|
2021
Q4 | $770K | Buy |
50,300
+8,000
| +19% | +$122K | ﹤0.01% | 707 |
|
|
2021
Q3 | $590K | Buy |
+42,300
| New | +$590K | ﹤0.01% | 772 |
|